Displaying drugs 1776 - 1800 of 6148 in total
Guaifenesin
Guaifenesin possesses a storied history, having been originally formally approved by the US FDA in 1952 and continues to be one of very few - if not perhaps the only drug that is readily available and used as an expectorant . Since that time the agent has been a combination...
Approved
Investigational
Vet approved
Matched Description: … antihistamines, and cough/cold combinations are not known to be safe and effective in children under the age of 6 …
Matched Mixtures name: … Zodryl DEC 50 ... BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BROKSIN 6.66 MG/5 ML+100 MG/5 ML SURUP, 150 ML …
Matched Products: … COFEN 50 COUGH MIXTURE 50 mg/5 ml ... GUARDIAN COUGH SYRUP 50 mg/5 ml ... COUGH RELIEF SYRUP 100 mg/5 ml …
Matched Mixtures name: … Zodryl DEC 50 ... BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BROKSIN 6.66 MG/5 ML+100 MG/5 ML SURUP, 150 ML …
Matched Products: … COFEN 50 COUGH MIXTURE 50 mg/5 ml ... GUARDIAN COUGH SYRUP 50 mg/5 ml ... COUGH RELIEF SYRUP 100 mg/5 ml …
Flumazenil
Fumazenil is an imidazobenzodiazepine derivative and a potent benzodiazepine receptor antagonist that competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex, thereby reversing the effects of benzodiazepine on the central nervous system.
Approved
Matched Iupac: … 5-carboxylate ... ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene- …
Matched Products: … LAUZENİL 0,5 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ANTİZEPİN 0,5 MG/5 ML İ.V. ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ANESED-R 0.5 MG/5 ML IV ENJEKSİYONLUK ÇÖZELTİ, 5 ADET …
Matched Products: … LAUZENİL 0,5 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ANTİZEPİN 0,5 MG/5 ML İ.V. ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ANESED-R 0.5 MG/5 ML IV ENJEKSİYONLUK ÇÖZELTİ, 5 ADET …
Caplacizumab
Caplacizumab, firstly called ALX-0081, is a humanized single-variable-domain immunoglobulin consisting of two identical humanized building blocks genetically linked by a three-alanine linker. Caplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019, and approved previously by the EU in October 2018 as a combination therapy...
Approved
Investigational
Matched Description: … Caplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019,[L5302] and …
Metoclopramide
Diabetic gastroparesis is a condition that causes frequent nausea and vomiting, which has a negative impact on quality of life and poses a significant burden on the healthcare system. Metoclopramide is a dopamine antagonist used to treat nausea and vomiting that may be associated with diabetic gastroparesis in addition to...
Approved
Investigational
Matched Synonyms: … 2-methoxy-5-chloroprocainamide ... 2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide ... 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide …
Matched Iupac: … 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide …
Matched Salts cas: … 7232-21-5 ... 54143-57-6 …
Matched Products: … PRIMPERAN 10 MG/2ML IM/IV AMPUL, 6 ADET ... TURKTIPSAN METOKLOPRAMID HIDROKLORÜR 10 MG/2 ML AMPUL, 6 ADET ... METOCLOPRAMIDE SYRUP 5 mg/5 ml …
Matched Iupac: … 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide …
Matched Salts cas: … 7232-21-5 ... 54143-57-6 …
Matched Products: … PRIMPERAN 10 MG/2ML IM/IV AMPUL, 6 ADET ... TURKTIPSAN METOKLOPRAMID HIDROKLORÜR 10 MG/2 ML AMPUL, 6 ADET ... METOCLOPRAMIDE SYRUP 5 mg/5 ml …
Sulbactam
Sulbactam is a beta (β)-lactamase inhibitor and a derivative of the basic penicillin nucleus. When given in combination with β-lactam antibiotics, sulbactam produces a synergistic effect as it blocks the enzyme responsible for drug resistance by hydrolyzing β-lactams.
Approved
Matched Products: … B-LAKTAM 1 GR IM/IV ENJEKTABL TOZ ICEREN FLAKON, 5 ADET ... ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 5 FLAKON …
Ornithine
Produced during the urea cycle, ornithine is an amino acid produced from the splitting off of urea from arginine. L-Ornithine allows for the disposal of excess nitrogen and acts as a precursor of citrulline and arginine.
Approved
Nutraceutical
Matched Salts cas: … 5191-97-9 …
Matched Mixtures name: … AMINOPLASMAL-5% E INFUSION …
Matched Products: … Hepasan 5 g - Brausepulver ... Hepa-Merz 5 g / 10 ml Infusionslösungs-Konzentrat ... HEPA-ORNITAT 5 G/10 ML INFÜZYON KONSANTRESI, 10 ADET …
Matched Mixtures name: … AMINOPLASMAL-5% E INFUSION …
Matched Products: … Hepasan 5 g - Brausepulver ... Hepa-Merz 5 g / 10 ml Infusionslösungs-Konzentrat ... HEPA-ORNITAT 5 G/10 ML INFÜZYON KONSANTRESI, 10 ADET …
Elafibranor
Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR) α and β/δ agonist. On June 10, 2024, elafibranor was granted accelerated approval by the FDA for the treatment of primary biliary cholangitis (PBC).
Approved
Investigational
Spesolimab
Spesolimab is an interleukin-36 (IL-36) receptor antagonist. It is a humanized monoclonal immunoglobulin G1 antibody that was produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. The biosimilar of the drug, spesolimab-sbzo, was first approved by the FDA in September 2022 to treat generalized pustular psoriasis flares. Spesolimab...
Approved
Investigational
Ezetimibe
Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The discovery and research of this drug began in the early 1990s, after the intravenous administration of radiolabelled ezetimibe in rats revealed that it was being localized within enterocytes of the intestinal villi - this prompted studies investigating...
Approved
Matched Mixtures name: … Rosamib 5 mg/10 mg Tabletten ... ROSALIN 10/5 MG TABLET, 84 ADET ... ROSALIN 10/5 MG TABLET, 28 ADET …
Nicorandil
Nicorandil is an orally efficacious vasodilatory drug and antianginal agent marketed in the UK, Australia, most of Europe, India, Philippines, Japan, South Korea, and Taiwan. It is not an approved drug by FDA. It is a niacinamide derivative that induces vasodilation of arterioles and large coronary arteries by activating potassium...
Approved
Investigational
Conjugated estrogens
The conjugated estrogens are noncrystalline mixtures of purified female sex hormones obtained either by its isolation from the urine of pregnant mares or by synthetic generation from vegetal material. Both of these products are later conjugated to natrium sulfate by ester bonds in order to make them more water soluble.[L5605,...
Approved
Matched Description: … [L5605, T475]
The conjugated estrogen product contains a mix of estrogen from which about 50% is ... followed by 25% of equilin sulfate, 15% of 17-alpha-dehydroequilenin sulfate, 3% of equilenin sulfate, 5% …
Vinblastine
Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)
Approved
Matched Iupac: … -ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5( ... 10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19 …
Matched Salts cas: … 143-67-9 …
Matched Products: … VINBLASTINE RICHTER 5 MG FLAKON …
Matched Salts cas: … 143-67-9 …
Matched Products: … VINBLASTINE RICHTER 5 MG FLAKON …
Nicardipine
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem]
Approved
Investigational
Matched Iupac: … 3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate …
Levamisole
Levamisole is an antihelminthic drug that was commonly used for the treatment of parasitic, viral, and bacterial infections. It was manufactured by Janssen and first used in 1969 as an agent to treat worm infestations Levamisole was approved by the FDA in 1990 as an adjuvant treatment for colon cancer....
Approved
Investigational
Vet approved
Withdrawn
Matched Iupac: … (6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole …
Matched Salts cas: … 16595-80-5 ... 32093-35-9 …
Matched Products: … PARAKS 40 MG TABLET, 6 ADET ... PARAKS 40 MG/5 ML ŞURUP, 30 ML ... SITRAKS 40 MG/5 ML SURUP, 30 ML …
Matched Salts cas: … 16595-80-5 ... 32093-35-9 …
Matched Products: … PARAKS 40 MG TABLET, 6 ADET ... PARAKS 40 MG/5 ML ŞURUP, 30 ML ... SITRAKS 40 MG/5 ML SURUP, 30 ML …
Indinavir
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
Approved
Matched Synonyms: … (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino …
Matched Salts cas: … 157810-81-6 …
Matched Salts cas: … 157810-81-6 …
Tolmetin
A non-steroidal anti-inflammatory agent (anti-inflammatory agents, NON-steroidal) similar in mode of action to indomethacin.
Approved
Matched Synonyms: … 1-Methyl-5-p-toluoylpyrrole-2-acetic acid ... 5-(p-Toluoyl)-1-methylpyrrole-2-acetic acid ... 1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid …
Matched Iupac: … 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid …
Matched Iupac: … 2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetic acid …
Lansoprazole
Lansoprazole marketed under the brand Prevacid, is a proton pump inhibitor (PPI) and is structurally classified as a substituted benzimidazole. It reduces gastric acid secretion by targeting gastric H,K-ATPase pumps and is thus effective at promoting healing in ulcerative diseases, and treating gastroesophageal reflux disease (GERD) along with other pathologies...
Approved
Investigational
Glasdegib
Glasdegib, also known as PF-04449913, is a small-molecule hedgehog signaling inhibitor selected under the group of benzimidazoles. In early research, benzimidazoles attracted large interest as they represented a class of inhibitors with low molecular weight, potent inhibitory activity, and lacking unstable functionality. The great lipophilicity of this group of compounds...
Approved
Investigational
Aminosalicylic acid
An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.
Approved
Matched Salts cas: … 133-09-5 ... 6018-19-5 …
Camphor
Camphor is a bicyclic monoterpene ketone found widely in plants, especially Cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. When ingested, camphor has a rapid onset of toxic effects, and camphorated oil is the product most often responsible for its toxicity. The FDA...
Approved
Withdrawn
Matched Mixtures name: … LINIMENTO VENECIANO Nº 9 ... OTACI TERMAL POMAD, 50 G ... CBD Clinic Pain Relief - Level 5 …
Leflunomide
Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD (disease-modifying antirheumatic drug) class of drugs, which are chemically and pharmacologically very heterogeneous. Leflunomide was approved by FDA and in many other countries (e.g., Canada, Europe) in 1999.
Approved
Investigational
Matched Synonyms: … 4-ISOXAZOLECARBOXAMIDE, 5-METHYL-N-(4-(TRIFLUOROMETHYL)PHENYL)- ... 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide ... 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide …
Matched Iupac: … 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide …
Matched Iupac: … 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide …
Zolpidem
Zolpidem, also known as Ambien, is a hypnotic drug that was initially approved by the FDA in 1992 [FDA label]. Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the...
Approved
Matched Synonyms: … N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide …
Matched Iupac: … N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide …
Matched Salts cas: … 99294-93-6 …
Matched Mixtures name: … Gabazolpidem-5 ... Sentrazolpidem PM-5 …
Matched Products: … SOMNIL 5 MG ... ZOLPIDEM 5 MG ... ZOLPIDEM-NEURAX 5 MG …
Matched Iupac: … N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide …
Matched Salts cas: … 99294-93-6 …
Matched Mixtures name: … Gabazolpidem-5 ... Sentrazolpidem PM-5 …
Matched Products: … SOMNIL 5 MG ... ZOLPIDEM 5 MG ... ZOLPIDEM-NEURAX 5 MG …
Menthol
Approved
Matched Iupac: … 5-methyl-2-(propan-2-yl)cyclohexan-1-ol …
Matched Mixtures name: … NuDroxiPAK DSDR-50 ... Dfs 1.5%/ms 25%/menth 6%/cap 0.025% Pak ... DFS 75mg DR/MS 25%/MENTH 6%/CAP 0.025% PAK …
Matched Products: … Op 6 Menthol Warming Roll On ... Op 6 Menthol Cooling Roll On ... Menthol 5% …
Matched Mixtures name: … NuDroxiPAK DSDR-50 ... Dfs 1.5%/ms 25%/menth 6%/cap 0.025% Pak ... DFS 75mg DR/MS 25%/MENTH 6%/CAP 0.025% PAK …
Matched Products: … Op 6 Menthol Warming Roll On ... Op 6 Menthol Cooling Roll On ... Menthol 5% …
Amivantamab
Amivantamab, also known as JNJ-61186372, is an anti-EGFR-MET bispecific antibody, derived from Chinese hamster ovary cells, approved for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose...
Approved
Investigational
Matched Description: … Amivantamab was granted FDA approval on 21 May 2021,[L34193] followed by the approval by the EMA on 9 …
Hydroxyurea
Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized biologically until 1928. It was first approved by the FDA in 1998 for the treatment of sickle cell anemia in adults. Although clinical evidence on the efficacy of hydroxyurea in certain conditions exists, hydroxyurea...
Approved
Displaying drugs 1776 - 1800 of 6148 in total